Glass tried the injections for his advanced disease, but they did not halt his vision loss. So his ophthalmologist tried ...

Sterling Glass had many health problems as a child—swollen feet, night sweats, nausea and vomiting, unquenchable thirst, and ...

DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New ...

According to Mordor Intelligence, cardiovascular drugs market is valued at USD 160.39 billion in 2025 and is projected to ...

Mounjaro recorded Rs 80 crore in sales in September, trailing only GSK's antibiotic Augmentin, which registered Rs 85 crore ...

Tramadol, a potent synthetic opioid, has been widely used to treat moderate to severe pain, but a new study suggests that the ...

Mounjaro recorded sales worth Rs 80 crore in September, compared with Rs 85 crore generated by Augmentin during the same period ...

FDA agrees with Phase 2b/3 clinical design, including primary endpoint and development approach, providing clear regulatory ...

Ozempic has taken TikTok by storm. It’s hailed as a miracle weight loss drug that helps you shed the pounds without even ...

Cheryl Fergison has revealed she's lost three stone on weight-loss injection Mounjaro - but says the so-called 'wonder drug' ...

Novo Nordisk saw a competitor’s bet and raised the stakes in metabolic dysfunction-associated steatohepatitis (MASH) with its planned up-to-$5.2 billion acquisition of Akero Therapeutics.

Casey Means, the surgeon general nominee, has criticized the medical establishment. She could be put in position to change it.